Remove 2022 Remove Packaging Remove Vaccines
article thumbnail

Moderna unveils $500m plan for African vaccine facility

pharmaphorum

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.

article thumbnail

STAT+: Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more

STAT

The comments came in response to an article  The Financial Times  that claimed the company is considered changing the location of a $578 million vaccine manufacturing plant from Liverpool to Philadelphia because the new U.K. and Japan, and have been in widespread use for mpox since 2022. The report said AZ had told the U.K.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Washington, DC, USA - June 24, 2022: The symbol of the U.S. Kennedy Jr.

article thumbnail

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? According to GlobalData epidemiologists, 437,425 people were on PrEP in the US in 2022, but this could be considerably higher, highlighting that drugs that help protect against HIV are not being maximised in the country.

article thumbnail

Parallel Trade 2022

pharmaphorum

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an end. Co-Chairs For 2022: Christopher Stothers, Partner,Freshfields Bruckhaus Deringer LLP. Policy Patent Operations.

article thumbnail

Sanofi agrees to invest $25m in Adagene

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? By GlobalData Learn more about Strategic Intelligence Expanding on their existing agreement from 2022, Sanofi has exercised an option within the partnership that allows it to select a third SAFEbody discovery programme. Don’t let policy changes catch you off guard.

article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

In 2022, the global market size of RNAi drug delivery was valued at $69.2B. Even though the company manages to generate a considerable revenue of $21.18M in 2022 through its collaborative agreements, Silence Therapeutics still waiting for the approval of its products. In 2022, the company generated total revenue of $1.04B.